Cite
Safety and Efficacy of Otaplimastat in Patients with Acute Ischemic Stroke Requiring tPA (SAFE-TPA): A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study.
MLA
Kim, Jong S., et al. “Safety and Efficacy of Otaplimastat in Patients with Acute Ischemic Stroke Requiring TPA (SAFE-TPA): A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study.” Annals of Neurology, vol. 87, no. 2, Feb. 2020, pp. 233–45. EBSCOhost, https://doi.org/10.1002/ana.25644.
APA
Kim, J. S., Lee, K. B., Park, J., Sung, S. M., Oh, K., Kim, E., Chang, D., Hwang, Y. H., Lee, E., Kim, W., Ju, C., Kim, B. S., Ryu, J., Park, J.-H., Kim, E.-G., Chang, D.-I., Lee, E.-J., Kim, W.-K., Ryu, J.-M., & SAFE-TPA Investigators. (2020). Safety and Efficacy of Otaplimastat in Patients with Acute Ischemic Stroke Requiring tPA (SAFE-TPA): A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study. Annals of Neurology, 87(2), 233–245. https://doi.org/10.1002/ana.25644
Chicago
Kim, Jong S., Kyung Bok Lee, Jong‐Ho Park, Sang Min Sung, Kyungmi Oh, Eung‐Gyu Kim, Dae‐il Chang, et al. 2020. “Safety and Efficacy of Otaplimastat in Patients with Acute Ischemic Stroke Requiring TPA (SAFE-TPA): A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study.” Annals of Neurology 87 (2): 233–45. doi:10.1002/ana.25644.